Docoh
Loading...

EYPT EyePoint Pharmaceuticals

Institutional ownership

Data for period
(Last complete reporting period)
Institutional shares
Float
Outstanding shares
Total positions
Opened positions
Closed positions
Increased positions
Decreased positions

Latest institutional filings

Type Filer #Shares Filed For date #Previous %Chg Prev. Date
13F-HR
Belvedere Trading 6.4K 19 Oct 21 30 Sep 21 0 +∞% 30 Jun 21
13F-HR
Cedar Mountain Advisors 1K 15 Oct 21 30 Sep 21 1K 0% 30 Jun 21
13F-HR/A
Bank Of America 4.81K 13 Sep 21 30 Jun 21 6.8K -29% 31 Mar 21
13F-HR/A
Marshall Wace North America 57.42K 26 Aug 21 31 Mar 21 0 +∞% 31 Dec 20
13F-HR/A
Marshall Wace North America 55.33K 25 Aug 21 30 Jun 21 57.42K -4% 31 Mar 21
13F-HR/A
Morgan Stanley 580 22 Aug 21 30 Jun 21 3.01K -81% 31 Mar 21
13F-HR/A
Ikarian Capital 208.5K 18 Aug 21 30 Jun 21 208.5K 0% 31 Mar 21
13F-HR/A
Ikarian Capital 208.5K 18 Aug 21 31 Mar 21 17.9K +1K% 31 Dec 20
13F-HR/A
Boothbay Fund Management 14.22K 17 Aug 21 30 Jun 21 14.22K 0% 31 Mar 21
13F-HR
Samsara BioCapital 450K 16 Aug 21 30 Jun 21 450K 0% 31 Mar 21

About this data

This data is updated daily from 13F, 13D and 13G SEC filings.

Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.

EYPT 5-year stock price

Institutional ownership trends

Institutional shares (*long positions only)
Number of holders
Opened vs closed positions (#holders, opened on top)
Increased vs decreased positions (#holders, increased on top)
Puts vs calls (#shares, puts on top)

Institutional ownership history data

All data in millions (MM) except percentages. "0.0" is < 100,000 and "0.0%" is < 0.1%
Filter holdings
Data to display
Shade data
Download data